Acute Myeloid Leukemia
Showing NaN - NaN of 91
Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell
Recruiting
- Acute Myeloid Leukemia
- +2 more
-
Brisbane, California
- +4 more
Jul 18, 2022
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Boston (biological, procedure, drug)
Terminated
- Myelodysplastic Syndrome
- +2 more
- GVAX
- +6 more
-
Boston, Massachusetts
- +3 more
Jun 30, 2022
Acute Myeloid Leukemia Trial in Boston (LY3214996)
Recruiting
- Acute Myeloid Leukemia
-
Boston, MassachusettsDana Farber Cancer Institute
Jun 6, 2022
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Worldwide (biological, drug, procedure)
Terminated
- Acute Myeloid Leukemia
- +2 more
- ATIR101
- +3 more
-
Duarte, California
- +41 more
Apr 28, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in France, United States (SY-1425 (tamibarotene), azacitidine,
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- SY-1425 (tamibarotene)
- +2 more
-
Hartford, Connecticut
- +25 more
May 4, 2022
Acute Myeloid Leukemia Trial in Canada, Puerto Rico, United States (procedure, drug, behavioral)
Recruiting
- Acute Myeloid Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- +13 more
-
Birmingham, Alabama
- +187 more
Apr 28, 2022
Blastic Plasmacytoid Dendritic Cell Tumor, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Worldwide (IMGN632)
Recruiting
- Blastic Plasmacytoid Dendritic Cell Neoplasm
- +3 more
-
Gilbert, Arizona
- +14 more
Apr 20, 2022
Acute Myeloid Leukemia Trial in Boston (Usual Care, Psychological intervention)
Active, not recruiting
- Acute Myeloid Leukemia
- Usual Care
- Psychological intervention
-
Boston, Massachusetts
- +1 more
Apr 5, 2022
Acute Myeloid Leukemia Trial in Worldwide (Uproleselan, Placebo)
Active, not recruiting
- Acute Myeloid Leukemia
- Uproleselan
- Placebo
-
La Jolla, California
- +69 more
Apr 5, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in Boston (Antithymocyte Globulin,
Active, not recruiting
- Acute Myeloid Leukemia
- +6 more
- Antithymocyte Globulin
- Clofarabine
-
Boston, Massachusetts
- +1 more
Jan 25, 2022
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Tumor Trial in United States (APR-246, Azacitidine)
Completed
- Myelodysplastic Syndrome
- +3 more
-
Tampa, Florida
- +5 more
Jan 14, 2022
Oncology, Acute Myeloid Leukemia Trial in United States (Open Label LAM-003)
Completed
- Oncology
- Acute Myeloid Leukemia
- Open Label LAM-003
-
New Haven, Connecticut
- +5 more
Dec 17, 2021
Acute Myeloid Leukemia, Non-Hodgkin's Lymphoma, Diffuse Large B-cell Lymphoma Trial in Australia, Germany, United States
Terminated
- Acute Myeloid Leukemia
- +2 more
- Venetoclax
- AMG 176
-
Duarte, California
- +16 more
Dec 3, 2021
GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)
Recruiting
- GVHD
- +15 more
- FLUDARABINE
- +6 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 30, 2021
Acute Myeloid Leukemia Trial in Singapore, United States (Cytarabine, Daunorubicin, Etoposide)
Philadelphia Positive Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Worldwide (STI571
Completed
- Philadelphia Positive Chronic Myeloid Leukemia
- +2 more
- STI571 400 mg
- STI571 600 mg
-
Boston, Massachusetts
- +11 more
Jul 1, 2021
Acute Myeloid Leukemia, Hematopoietic and Lymphoid System Tumor, Myelodysplastic Syndrome Trial in United States (Azacitidine,
Recruiting
- Acute Myeloid Leukemia
- +5 more
- Azacitidine
- +2 more
-
Boston, Massachusetts
- +3 more
Jun 30, 2021
Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Boston (Lenalidomide, Velcade)
Active, not recruiting
- Myelodysplastic Syndrome
- Acute Myeloid Leukemia
-
Boston, Massachusetts
- +1 more
Jun 22, 2021
Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms
Not yet recruiting
- Pyruvate Kinase Deficiency
- +10 more
- Blood Draw
-
Boston, MassachusettsMassachusetts General Hospital
May 21, 2021
Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in Worldwide (MCLA-117 bispecific antibody)
Active, not recruiting
- Acute Myelogenous Leukemia
- Acute Myeloid Leukemia
- MCLA-117 bispecific antibody
-
Augusta, Georgia
- +9 more
May 6, 2021
Acute Myeloid Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia Trial in Canada, Puerto Rico, United
Completed
- Acute Myeloid Leukemia
- +27 more
- Caspofungin Acetate
- +2 more
-
Birmingham, Alabama
- +178 more
Mar 26, 2021